BioXcel Therapeutics, Inc. (DUS:BX20) Financings

BioXcel Therapeutics, Inc.

Financings

RaiseDate
At-the-market programme of common stock
Closed: US$11.5M raised
Aug 12, 2025
Warrant exercise of outstanding warrants
Closed: US$3.6M raised
Aug 12, 2025
Registered direct offering of shares of common stock (or common stock equivalents) and accompanying warrants
Closed: US$14M raised · US$3.5 a share · Warrants at US$4.2 for 60 months · Rodman & Renshaw LLC
Dealers: Rodman & Renshaw LLC (lead)
Use of proceeds: Working capital and general corporate purposes
Mar 4, 2025

Read by 6ix AI from the company's releases